Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Maintains Neutral on AbbVie, Lowers Price Target to $162

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $178 to $162.
byBenzinga Newsdesk
August 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Atlantic Equities analyst Steve Chesney maintains AbbVie (NYSE:ABBV) with a Neutral and lowers the price target from $178 to $162.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Boeing’s China Deliveries Hit By Regulatory Battery Review: Report

By Shivani Kumaresan
May 23, 6:57 AM
Deliveries of Boeing aircraft to China face delays as Chinese regulators review the batteries in the cockpit voice recorder. Boeing is working with Chinese clients to manage delivery schedules while awaiting the Civil Aviation Administration of China's (CAAC) evaluation. The company disclosed having around 140 737 MAX 8 aircraft in stock, with 85 intended for Chinese customers, impacting their delivery timelines.

BA